Metformin and 5-fluorouracil for Refractory Colorectal Cancer.
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This is a phase II trial to evaluate efficacy and safety of Metformin and Fluorouracil in
patients with metastatic colorectal cancer (CRC) who have progressed after Oxaliplatin and
Irinotecan based chemotherapy.